What Do Tesla Delivery Numbers Mean for Tesla Stock?
Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…
Sell
33
AMRN Quote, Financials, Valuation and Earnings
Last price:
$9.06
Seasonality move
:
-5.38%
Day range:
$8.74 - $10.10
52-week range:
$7.08 - $20.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.84x
P/B ratio:
0.40x
Volume:
295.9K
Avg. volume:
109.8K
1-year change:
-54.41%
Market cap:
$192.6M
Revenue:
$228.6M
EPS (TTM):
-$0.20
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AMRN
Amarin Corp PLC
|
$50.3M | -$0.40 | -28.71% | -- | $20.00 |
|
ALKS
Alkermes PLC
|
$305M | $0.24 | -13.14% | -12.17% | $39.71 |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$984.2M | $4.76 | 9.16% | 309.21% | $192.72 |
|
MDT
Medtronic PLC
|
$8.3B | $1.36 | 2.59% | 221.68% | $96.83 |
|
PRGO
Perrigo Co PLC
|
$1.1B | $0.54 | 0.89% | 5337.6% | $34.60 |
|
TRIB
Trinity Biotech PLC
|
$16M | -$0.28 | 8.81% | -25.13% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AMRN
Amarin Corp PLC
|
$9.30 | $20.00 | $192.6M | -- | $0.00 | 0% | 0.84x |
|
ALKS
Alkermes PLC
|
$27.00 | $39.71 | $4.4B | 12.44x | $0.00 | 0% | 2.93x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$100.50 | $192.72 | $6.1B | 11.43x | $0.00 | 0% | 1.59x |
|
MDT
Medtronic PLC
|
$82.90 | $96.83 | $106.3B | 25.20x | $0.70 | 3.38% | 3.24x |
|
PRGO
Perrigo Co PLC
|
$24.64 | $34.60 | $3.4B | -- | $0.29 | 4.54% | 0.77x |
|
TRIB
Trinity Biotech PLC
|
$0.58 | -- | $11.1M | -- | $0.00 | 0% | 0.11x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AMRN
Amarin Corp PLC
|
-- | 0.049 | -- | 2.31x |
|
ALKS
Alkermes PLC
|
-- | 1.084 | -- | 2.45x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
59.88% | 0.953 | 81.81% | 3.57x |
|
MDT
Medtronic PLC
|
34.97% | 0.718 | 22.74% | 1.19x |
|
PRGO
Perrigo Co PLC
|
45.58% | -0.127 | 103.15% | 1.15x |
|
TRIB
Trinity Biotech PLC
|
147.47% | -0.355 | 785.94% | 0.87x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AMRN
Amarin Corp PLC
|
-$9.6M | -$52.5M | -15.41% | -15.41% | -60.86% | -$13.3M |
|
ALKS
Alkermes PLC
|
$367.9M | $162.7M | 23.97% | 28.24% | 40.59% | $180.6M |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$959.5M | $190.8M | 5.74% | 14.39% | 16.95% | $385.3M |
|
MDT
Medtronic PLC
|
$5.5B | $1.7B | 5.58% | 8.56% | 20.73% | $2.1B |
|
PRGO
Perrigo Co PLC
|
$385.9M | $164.8M | -1.98% | -3.76% | 9.94% | $274.9M |
|
TRIB
Trinity Biotech PLC
|
$5.3M | -$2.2M | -45.03% | -- | -11.29% | -$6.3M |
Amarin Corp PLC vs. Competitors
-
Which has Higher Returns AMRN or ALKS?
Alkermes PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of 34.07%. Amarin Corp PLC's return on equity of -15.41% beat Alkermes PLC's return on equity of 28.24%.
Company Gross Margin Earnings Per Share Invested Capital AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M ALKSAlkermes PLC85.55% $0.88 $1.5B -
What do Analysts Say About AMRN or ALKS?
Amarin Corp PLC has a consensus price target of $20.00, signalling upside risk potential of 115.05%. On the other hand Alkermes PLC has an analysts' consensus of $39.71 which suggests that it could grow by 47.09%. Given that Amarin Corp PLC has higher upside potential than Alkermes PLC, analysts believe Amarin Corp PLC is more attractive than Alkermes PLC.
Company Buy Ratings Hold Ratings Sell Ratings AMRNAmarin Corp PLC0 1 0 ALKSAlkermes PLC8 6 0 -
Is AMRN or ALKS More Risky?
Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Alkermes PLC has a beta of 0.389, suggesting its less volatile than the S&P 500 by 61.101%.
-
Which is a Better Dividend Stock AMRN or ALKS?
Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alkermes PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Alkermes PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AMRN or ALKS?
Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Alkermes PLC quarterly revenues of $430M. Amarin Corp PLC's net income of -$48.6M is lower than Alkermes PLC's net income of $146.5M. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Alkermes PLC's PE ratio is 12.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.84x versus 2.93x for Alkermes PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AMRNAmarin Corp PLC0.84x -- $62.3M -$48.6M ALKSAlkermes PLC2.93x 12.44x $430M $146.5M
-
Which has Higher Returns AMRN or JAZZ?
Jazz Pharmaceuticals PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of 17.56%. Amarin Corp PLC's return on equity of -15.41% beat Jazz Pharmaceuticals PLC's return on equity of 14.39%.
Company Gross Margin Earnings Per Share Invested Capital AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M JAZZJazz Pharmaceuticals PLC88.17% $3.11 $10.2B -
What do Analysts Say About AMRN or JAZZ?
Amarin Corp PLC has a consensus price target of $20.00, signalling upside risk potential of 115.05%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $192.72 which suggests that it could grow by 91.76%. Given that Amarin Corp PLC has higher upside potential than Jazz Pharmaceuticals PLC, analysts believe Amarin Corp PLC is more attractive than Jazz Pharmaceuticals PLC.
Company Buy Ratings Hold Ratings Sell Ratings AMRNAmarin Corp PLC0 1 0 JAZZJazz Pharmaceuticals PLC10 2 0 -
Is AMRN or JAZZ More Risky?
Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.419, suggesting its less volatile than the S&P 500 by 58.096%.
-
Which is a Better Dividend Stock AMRN or JAZZ?
Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AMRN or JAZZ?
Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Jazz Pharmaceuticals PLC quarterly revenues of $1.1B. Amarin Corp PLC's net income of -$48.6M is lower than Jazz Pharmaceuticals PLC's net income of $191.1M. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 11.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.84x versus 1.59x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AMRNAmarin Corp PLC0.84x -- $62.3M -$48.6M JAZZJazz Pharmaceuticals PLC1.59x 11.43x $1.1B $191.1M
-
Which has Higher Returns AMRN or MDT?
Medtronic PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of 15.61%. Amarin Corp PLC's return on equity of -15.41% beat Medtronic PLC's return on equity of 8.56%.
Company Gross Margin Earnings Per Share Invested Capital AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M MDTMedtronic PLC66.49% $1.01 $76.2B -
What do Analysts Say About AMRN or MDT?
Amarin Corp PLC has a consensus price target of $20.00, signalling upside risk potential of 115.05%. On the other hand Medtronic PLC has an analysts' consensus of $96.83 which suggests that it could grow by 16.81%. Given that Amarin Corp PLC has higher upside potential than Medtronic PLC, analysts believe Amarin Corp PLC is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings AMRNAmarin Corp PLC0 1 0 MDTMedtronic PLC11 14 1 -
Is AMRN or MDT More Risky?
Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.794, suggesting its less volatile than the S&P 500 by 20.554%.
-
Which is a Better Dividend Stock AMRN or MDT?
Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medtronic PLC offers a yield of 3.38% to investors and pays a quarterly dividend of $0.70 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Medtronic PLC pays out 99.73% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AMRN or MDT?
Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Medtronic PLC quarterly revenues of $8.3B. Amarin Corp PLC's net income of -$48.6M is lower than Medtronic PLC's net income of $1.3B. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 25.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.84x versus 3.24x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AMRNAmarin Corp PLC0.84x -- $62.3M -$48.6M MDTMedtronic PLC3.24x 25.20x $8.3B $1.3B
-
Which has Higher Returns AMRN or PRGO?
Perrigo Co PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of -3.91%. Amarin Corp PLC's return on equity of -15.41% beat Perrigo Co PLC's return on equity of -3.76%.
Company Gross Margin Earnings Per Share Invested Capital AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M PRGOPerrigo Co PLC33.9% -$0.32 $7.9B -
What do Analysts Say About AMRN or PRGO?
Amarin Corp PLC has a consensus price target of $20.00, signalling upside risk potential of 115.05%. On the other hand Perrigo Co PLC has an analysts' consensus of $34.60 which suggests that it could grow by 40.42%. Given that Amarin Corp PLC has higher upside potential than Perrigo Co PLC, analysts believe Amarin Corp PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings AMRNAmarin Corp PLC0 1 0 PRGOPerrigo Co PLC1 3 0 -
Is AMRN or PRGO More Risky?
Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Perrigo Co PLC has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.326%.
-
Which is a Better Dividend Stock AMRN or PRGO?
Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perrigo Co PLC offers a yield of 4.54% to investors and pays a quarterly dividend of $0.29 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Perrigo Co PLC pays out -88.77% of its earnings as a dividend.
-
Which has Better Financial Ratios AMRN or PRGO?
Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Perrigo Co PLC quarterly revenues of $1.1B. Amarin Corp PLC's net income of -$48.6M is lower than Perrigo Co PLC's net income of -$44.5M. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Perrigo Co PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.84x versus 0.77x for Perrigo Co PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AMRNAmarin Corp PLC0.84x -- $62.3M -$48.6M PRGOPerrigo Co PLC0.77x -- $1.1B -$44.5M
-
Which has Higher Returns AMRN or TRIB?
Trinity Biotech PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of -31.41%. Amarin Corp PLC's return on equity of -15.41% beat Trinity Biotech PLC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M TRIBTrinity Biotech PLC35.03% -$0.46 $55.5M -
What do Analysts Say About AMRN or TRIB?
Amarin Corp PLC has a consensus price target of $20.00, signalling upside risk potential of 115.05%. On the other hand Trinity Biotech PLC has an analysts' consensus of -- which suggests that it could grow by 2486.21%. Given that Trinity Biotech PLC has higher upside potential than Amarin Corp PLC, analysts believe Trinity Biotech PLC is more attractive than Amarin Corp PLC.
Company Buy Ratings Hold Ratings Sell Ratings AMRNAmarin Corp PLC0 1 0 TRIBTrinity Biotech PLC0 0 0 -
Is AMRN or TRIB More Risky?
Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Trinity Biotech PLC has a beta of 1.210, suggesting its more volatile than the S&P 500 by 20.986%.
-
Which is a Better Dividend Stock AMRN or TRIB?
Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Trinity Biotech PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Trinity Biotech PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AMRN or TRIB?
Amarin Corp PLC quarterly revenues are $62.3M, which are larger than Trinity Biotech PLC quarterly revenues of $15.2M. Amarin Corp PLC's net income of -$48.6M is lower than Trinity Biotech PLC's net income of -$4.8M. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Trinity Biotech PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.84x versus 0.11x for Trinity Biotech PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AMRNAmarin Corp PLC0.84x -- $62.3M -$48.6M TRIBTrinity Biotech PLC0.11x -- $15.2M -$4.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Chewy a Growth Stock to Buy?
It might be a surprise to learn that during the…
Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
